Article

Toll-like receptor 2 ligands on the staphylococcal cell wall downregulate superantigen-induced T cell activation and prevent toxic shock syndrome.

FOCIS Centre for Clinical Immunology and Immunotherapeutics, Robarts Research Institute, London, Ontario, Canada.
Nature medicine (impact factor: 27.14). 07/2009; 15(6):641-8. DOI:10.1038/nm.1965 pp.641-8
Source: PubMed

ABSTRACT Staphylococcal superantigens are pyrogenic exotoxins that cause massive T cell activation leading to toxic shock syndrome and death. Despite the strong adaptive immune response induced by these toxins, infections by superantigen-producing staphylococci are very common clinical events. We hypothesized that this may be partly a result of staphylococcal strains having developed strategies that downregulate the T cell response to these toxins. Here we show that the human interleukin-2 response to staphylococcal superantigens is inhibited by the simultaneous presence of bacteria. Such a downregulatory effect is the result of peptidoglycan-embedded molecules binding to Toll-like receptor 2 and inducing interleukin-10 production and apoptosis of antigen-presenting cells. We corroborated these findings in vivo by showing substantial prevention of mortality after simultaneous administration of staphylococcal enterotoxin B with either heat-killed staphylococci or Staphylococcus aureus peptidoglycan in mouse models of superantigen-induced toxic shock syndrome.

0 0
 · 
0 Bookmarks
 · 
36 Views

Keywords

bacteria
 
cause massive T cell activation
 
downregulatory effect
 
human interleukin-2 response
 
infections
 
mouse models
 
peptidoglycan-embedded molecules binding
 
simultaneous administration
 
simultaneous presence
 
staphylococcal enterotoxin B
 
staphylococcal strains
 
Staphylococcal superantigens
 
Staphylococcus aureus peptidoglycan
 
strong adaptive immune response induced
 
substantial prevention
 
superantigen-induced toxic shock syndrome
 
T cell response
 
Toll-like receptor 2
 
toxic shock syndrome
 
toxins